The European Medicines Agency

Within the European Union, all cancer drugs need to be approved by the European Medicines Agency. However, the availability and price of each cancer drug may vary from country to country.

Cancer treatments approved in Europe

Click on the cancer type below for a list of the traditional and immuno-oncology treatments currently approved by the European Medicines Agency. The European Medicines Agency publishes summary information on each treatment in 22 languages.

Adrenal cortex neoplasms (adrenal cortex cancer)

Breast neoplasms (breast cancer)

Carcinoma, basal cell

Carcinoma, non-small-cell lung

Carcinoma, small cell lung

Carcinoma, renal cell

Carcinoma, hepatocellular

Cervical neoplasms (cervical cancer)

Colonic neoplasms (colon cancer)

Colorectal neoplasms (colorectal cancer)

Hodgkin disease

Gastric adenocarcinoma

Gastrointestinal stromal tumours

Leukemia

Leukemia, lymphocytic, chronic, B-Cell

Leukemia, myeloid

Meningeal neoplasms

Melanoma

Mesothelioma

Multiple myeloma

Ovarian neoplasms (ovarian cancer)

Pancreatic neoplasms (pancreatic cancer)

Parathyroid neoplasms

Prostatic neoplasms (prostate cancer)

Stomach neoplasms (stomach cancer)

Sarcoma, renal-cell sarcoma (renal-cell carcinoma)

Sarcoma, Kaposi's (Kaposi sarcoma)

Thyroid neoplasms (thyroid cancer)